Influence of Atorvastatin on Number of Endothelial Progenitor Cells in Peripheral Blood in Patients with Different Types of Coronary Heart Disease

ZHANG Jing,QU Peng
DOI: https://doi.org/10.3969/j.issn.1008-0074.2012.02.17
2012-01-01
Abstract:Objective: To study influence of atorvastatin on number of endothelial progenitor cells(EPCs) in peripheral blood in patients with different types of coronary heart disease(CHD).Methods:A total of 127 CHD patients were divided into acute myocardial infarction(AMI) + percutaneous coronary intervention group(group A,n=45),AMI + conservative treatment group(group B,n=29),unstable angina pectoris group(group C,n=31) and stable angina pectoris group(group D,n=22).All above patients received atorvastatin therapy after admission.Another 30 no-CHD patients were regard as no-CHD control group and they no received atorvastatin.All patients were taken blood sample instant,14d and 30d after admission for measurement of number of EPCs marked by CD133 in peripheral blood.Results:There were expression of EPCs(CD133) in peripheral blood of CHD patients and no-CHD control group.Compared with instant after admission,there were significant increase of EPCs(CD133) in CHD patients on 14d and 30d [group A:(0.015±0.016)% vs.(0.411±0.361)% vs.(0.472±0.384)%,group B:(0.009±0.010)% vs.(0.250±0.031)% vs.(0.413±0.035)%,group C:(0.421±0.814)% vs.(1.065±2.014)% vs.(1.325±2.321)%,group D:(1.387±0.021)% vs.(2.153±0.167)% vs.(3.052±0.086)%]after atorvastatin therapy,P0.05 all;there were no significant change of expression of EPCs(CD133) in no-CHD control group on 14d and 30d(P0.05).Conclusion: Atorvastatin can increase number of endothelial progenitor cells in peripheral blood of patients with coronary heart disease.
What problem does this paper attempt to address?